AbbVie Inc (ABBV)
Operating profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 9,137,000 | 13,822,000 | 12,272,000 | 12,787,000 | 12,757,000 | 15,064,000 | 17,386,000 | 16,168,000 | 18,117,000 | 17,689,000 | 17,392,000 | 18,538,000 | 17,924,000 | 16,603,000 | 15,552,000 | 11,863,000 | 11,363,000 | 11,566,000 | 10,928,000 | 13,576,000 |
| Revenue (ttm) | US$ in thousands | 56,334,000 | 55,533,000 | 55,000,000 | 54,403,000 | 54,318,000 | 55,138,000 | 56,023,000 | 56,741,000 | 58,054,000 | 57,819,000 | 57,349,000 | 56,725,000 | 56,197,000 | 55,169,000 | 53,729,000 | 50,195,000 | 45,804,000 | 40,650,000 | 36,227,000 | 34,057,000 |
| Operating profit margin | 16.22% | 24.89% | 22.31% | 23.50% | 23.49% | 27.32% | 31.03% | 28.49% | 31.21% | 30.59% | 30.33% | 32.68% | 31.89% | 30.09% | 28.95% | 23.63% | 24.81% | 28.45% | 30.17% | 39.86% |
December 31, 2024 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $9,137,000K ÷ $56,334,000K
= 16.22%
The operating profit margin of AbbVie Inc has shown fluctuations over the past several quarters. Starting at a strong 39.86% in March 2020, the operating profit margin declined to 22.31% in June 2024 before dipping further to 16.22% by December 2024. Despite these drops, there were periods of recovery and growth, such as in March 2022 when the margin rose to 32.68% and in December 2022 when it reached 31.21%.
Overall, the trend indicates some inconsistency in AbbVie Inc's operating profit margin performance, with a general downward trajectory over the period from mid-2022 to the end of 2024. This could be a point of concern for investors and stakeholders, suggesting potential challenges in maintaining profitability or controlling costs. Further analysis would be needed to understand the specific factors driving these fluctuations and to assess the company's overall financial health and strategic direction.
Peer comparison
Dec 31, 2024